The present study was designed to determine the effects of oral administration of the nitric oxide-precursor Larginine, in combination with the alpha2 blocker yohimbine, on subjective and physiological (vaginal photoplethysmography) responses to erotic stimuli in postmenopausal women with Female Sexual Arousal Disorder (FSAD).